Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × ixabepilone × Clear all

Adenocarcinoma, Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT00058084 2017-02-23

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Phase 2 Completed

80 enrolled

Genitourinary

Prostatic Neoplasms

NCT00016393 2013-06-24

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Genitourinary

Prostatic Neoplasms

Clinical Trials

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy